3,385
Views
39
CrossRef citations to date
0
Altmetric
Review

Rotavirus vaccination and intussusception – Science, surveillance, and safety: A review of evidence and recommendations for future research priorities in low and middle income countries

, , , , , , & , PhD show all
Pages 2580-2589 | Received 16 Mar 2016, Accepted 25 May 2016, Published online: 28 Jul 2016

References

  • World Health Organization. Rotavirus vaccines:an update. Wkly Epidemiol Rec 2009; 84:533-40; PMID:20034143
  • World Health Organization. Rotavirus vaccines. WHO position paper - January 2013. Wkly Epidemiol Rec 2013; 88:49-64; PMID:23424730
  • PATH. Rotavirus vaccine access and delivery: country introductions of rotavirus vaccines 2015; [cited 30 November 2015]; available from: http://sites.path.org/rotavirusvaccine/country-introductio-maps-and-spreadsheet/
  • Aliabadi N, Tate JE, Haynes AK, Parashar UD. Sustained decrease in laboratory detection of rotavirus after implementation of routine vaccination - United States, 2000–2014. MMWR Morb Mortal Wkly Rep 2015; 64:337-42; PMID:25856253
  • Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, Akikusa JD, Kelly JJ, Kirkwood CD. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule. Pediatr Infect Dis J 2011; 30:S25-9; PMID:21183837; http://dx.doi.org/10.1097/INF.0b013e3181fefdee
  • Cortese MM, Tate JE, Simonsen L, Edelman L, Parashar UD. Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases. Pediatr Infect Dis J 2010; 29:489-94; PMID:20354464
  • do Carmo GM, Yen C, Cortes J, Siqueira AA, de Oliveira WK, Cortez-Escalante JJ, Lopman B, Flannery B, de Oliveira LH, Carmo EH, et al. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med 2011; 8:e1001024; PMID:21526228; http://dx.doi.org/10.1371/journal.pmed.1001024
  • Esparza-Aguilar M, Gastanaduy PA, Sanchez-Uribe E, Desai R, Parashar UD, Richardson V, Patel M. Diarrhoea-related hospitalizations in children before and after implementation of monovalent rotavirus vaccination in Mexico. Bull World Health Organ 2014; 92:117-25; PMID:24623905; http://dx.doi.org/10.2471/BLT.13.125286
  • Leshem E, Moritz RE, Curns AT, Zhou F, Tate JE, Lopman BA, Parashar UD. Rotavirus vaccines and health care utilization for diarrhea in the United States (2007–2011). Pediatrics 2014; 134:15-23; PMID:24913793; http://dx.doi.org/10.1542/peds.2013–3849
  • Msimang VM, Page N, Groome MJ, Moyes J, Cortese MM, Seheri M, Kahn K, Chagan M, Madhi SA, Cohen C. Impact of rotavirus vaccine on childhood diarrheal hospitalization after introduction into the South African public immunization program. Pediatr Infect Dis J 2013; 32:1359-64; PMID:24569308; http://dx.doi.org/10.1097/INF.0b013e3182a72fc0
  • Paulke-Korinek M, Kollaritsch H, Aberle SW, Zwazl I, Schmidle-Loss B, Vecsei A, Kundi M. Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria. Vaccine 2013; 31:2686-91; PMID:23597718; http://dx.doi.org/10.1016/j.vaccine.2013.04.001
  • Payne DC, Selvarangan R, Azimi PH, Boom JA, Englund JA, Staat MA, Halasa NB, Weinberg GA, Szilagyi PG, Chappell J, et al. Long-term consistency in rotavirus vaccine protection: RV5 and RV1 vaccine effectiveness in US children, 2012–2013. Clinl Infect Dis 2015; 61:1792-9; PMID:26449565; http://dx.doi.org/10.1093/cid/civ872
  • Raes M, Strens D, Vergison A, Verghote M, Standaert B. Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium. Pediatr Infect Dis J 2011; 30:e120-5; PMID:21436757; http://dx.doi.org/10.1097/INF.0b013e318214b811
  • Yen C, Armero Guardado JA, Alberto P, Rodriguez Araujo DS, Mena C, Cuellar E, Nolasco JB, De Oliveira LH, Pastor D, Tate JE, et al. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. Pediatr Infect Dis J 2011; 30:S6-S10; PMID:21048524; http://dx.doi.org/10.1097/INF.0b013e3181fefa05
  • Cortese MM, Dahl RM, Curns AT, Parashar UD. Protection against gastroenteritis in US households with children who received rotavirus vaccine. J Infect Dis 2015; 211:558-62; PMID:25234721; http://dx.doi.org/10.1093/infdis/jiu503
  • Lopman BA, Curns AT, Yen C, Parashar UD. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis 2011; 204:980-6; PMID:21878425; http://dx.doi.org/10.1093/infdis/jir492
  • Payne DC, Staat MA, Edwards KM, Szilagyi PG, Weinberg GA, Hall CB, Chappell J, Curns AT, Wikswo M, Tate JE, et al. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006–2009. Clinl Infect Dis 2011; 53:245-53; PMID:21705316; http://dx.doi.org/10.1093/cid/cir307
  • Centers for Disease Control and Prevention. Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep 1999; 48:1007; PMID:10577495
  • Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, Zanardi LR, Setia S, Fair E, LeBaron CW, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 2001; 344:564-72; PMID:11207352; http://dx.doi.org/10.1056/NEJM200102223440804
  • Peter G, Myers MG, National Vaccine Advisory Committee, National Vaccine Program Office. Intussusception, rotavirus, and oral vaccines: summary of a workshop. Pediatrics 2002; 110:e67; PMID:12456934; http://dx.doi.org/10.1542/peds.110.6.e67
  • Food and Drug Administration. February 3, 2006 approval letter - RotaTeq 2006; [cited 28 April 2016]; available from: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm142303.htm
  • Food and Drug Administration. April 3, 2008 approval letter - Rotarix 2008; [cited 28 April 2016]; available from: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm133541.htm
  • Buttery JP, Danchin MH, Lee KJ, Carlin JB, McIntyre PB, Elliott EJ, Booy R, Bines JE, Group PAS. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 2011; 29:3061-6; PMID:21316503; http://dx.doi.org/10.1016/j.vaccine.2011.01.088
  • Haber P, Patel M, Pan Y, Baggs J, Haber M, Museru O, Yue X, Lewis P, Destefano F, Parashar UD. Intussusception after rotavirus vaccines reported to US VAERS, 2006–2012. Pediatrics 2013; 131:1042-9; PMID:23669521; http://dx.doi.org/10.1542/peds.2012–2554
  • Patel MM, Lopez-Collada VR, Bulhoes MM, De Oliveira LH, Bautista Marquez A, Flannery B, Esparza-Aguilar M, Montenegro Renoiner EI, Luna-Cruz ME, Sato HK, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med 2011; 364:2283-92; PMID:21675888; http://dx.doi.org/10.1056/NEJMoa1012952
  • Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11-22; PMID:16394298; http://dx.doi.org/10.1056/NEJMoa052434
  • Shui IM, Baggs J, Patel M, Parashar UD, Rett M, Belongia EA, Hambidge SJ, Glanz JM, Klein NP, Weintraub E. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA 2012; 307:598-604; PMID:22318281; http://dx.doi.org/10.1001/jama.2012.97
  • Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23-33; PMID:16394299; http://dx.doi.org/10.1056/NEJMoa052664
  • Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, Klein NP, Glanz JM, Jacobsen SJ, Naleway A, et al. Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med 2014; 370:513-9; PMID:24422678; http://dx.doi.org/10.1056/NEJMoa1311738
  • Yih WK, Lieu TA, Kulldorff M, Martin D, McMahill-Walraven CN, Platt R, Selvam N, Selvan M, Lee GM, Nguyen M. Intussusception risk after rotavirus vaccination in U.S. infants. N Engl J Med 2014; 370:503-12; PMID:24422676; http://dx.doi.org/10.1056/NEJMoa1303164
  • Tate JE, Steele AD, Bines JE, Zuber PL, Parashar UD. Research priorities regarding rotavirus vaccine and intussusception: a meeting summary. Vaccine 2012; 30(Suppl 1):A179-84; PMID:22520129; http://dx.doi.org/10.1016/j.vaccine.2011.08.110
  • World Health Organization. Rotavirus vaccine and intussusception:report from an expert consultation. Wkly Epidemiol Rec 2011; 86:317-21; PMID:21800466
  • Patel MM, Clark AD, Sanderson CF, Tate J, Parashar UD. Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysis. PLoS Med 2012; 9:e1001330; PMID:23109915; http://dx.doi.org/10.1371/journal.pmed.1001330
  • Groome MJ, Page N, Cortese MM, Moyes J, Zar HJ, Kapongo CN, Mulligan C, Diedericks R, Cohen C, Fleming JA, et al. Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study. Lancet Infect Dis 2014; 14:1096-104; PMID:25303843; http://dx.doi.org/10.1016/S1473-3099(14)70940-5
  • Tate JE, Parashar UD. Rotavirus vaccines in routine use. Clinl Infect Dis 2014; 59:1291-301; PMID:25048849; http://dx.doi.org/10.1093/cid/ciu564
  • Yen C, Tate JE, Hyde TB, Cortese MM, Lopman BA, Jiang B, Glass RI, Parashar UD. Rotavirus vaccines: current status and future considerations. Human Vaccin Immunother 2014; 10:1436-48; PMID:24755452; http://dx.doi.org/10.4161/hv.28857
  • Roeyen G, Jansen M, Hubens G, Vaneerdeweg W, Eyskens E. Intussusception in infants: an emergency in diagnosis and treatment. Eur J Emerg Med 1999; 6:73-6; PMID:10340739
  • Stringer MD, Pablot SM, Brereton RJ. Paediatric intussusception. Br J Surg 1992; 79:867-76; PMID:1422744; http://dx.doi.org/10.1002/bjs.1800790906
  • Bines JE, Liem NT, Justice FA, Son TN, Kirkwood CD, de Campo M, Barnett P, Bishop RF, Robins-Browne R, Carlin JB, et al. Risk factors for intussusception in infants in Vietnam and Australia: adenovirus implicated, but not rotavirus. J Pediatri 2006; 149:452-60; PMID:17011313; http://dx.doi.org/10.1016/j.jpeds.2006.04.010
  • Jiang J, Jiang B, Parashar U, Nguyen T, Bines J, Patel MM. Childhood intussusception: a literature review. PloS One 2013; 8:e68482; PMID:23894308; http://dx.doi.org/10.1371/journal.pone.0068482
  • Clarke EJ, Jr., Phillips IA, Alexander ER. Adenovirus infection in intussusception in children in Taiwan. Jama 1969; 208:1671-4; PMID:4305625; http://dx.doi.org/10.1001/jama.1969.03160090031007
  • May AN, Piper SM, Boutlis CS. Yersinia intussusception: case report and review. J Paediatri Child Health 2014; 50:91-5; PMID:23711231; http://dx.doi.org/10.1111/jpc.12240
  • Minney-Smith CA, Levy A, Hodge M, Jacoby P, Williams SH, Carcione D, Roczo-Farkas S, Kirkwood CD, Smith DW. Intussusception is associated with the detection of adenovirus C, enterovirus B and rotavirus in a rotavirus vaccinated population. J Clin Virol 2014; 61:579-84; PMID:25464971; http://dx.doi.org/10.1016/j.jcv.2014.10.018
  • Nylund CM, Denson LA, Noel JM. Bacterial enteritis as a risk factor for childhood intussusception: a retrospective cohort study. J Pediatri 2010; 156:761-5; PMID:20138300; http://dx.doi.org/10.1016/j.jpeds.2009.11.026
  • DiFiore JW. Intussusception. Semin Pediatr Surg 1999; 8:214-20; PMID:10573432; http://dx.doi.org/10.1016/S1055-8586(99)70029-6
  • Pang LC. Intussusception revisited: clinicopathologic analysis of 261 cases, with emphasis on pathogenesis. South Med J 1989; 82:215-28; PMID:2916150; http://dx.doi.org/10.1097/00007611-198902000-00017
  • Centers for Disease Control and Prevention. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999; 48:1-20; PMID:10219046
  • Rennels MB, Parashar UD, Holman RC, Le CT, Chang HG, Glass RI. Lack of an apparent association between intussusception and wild or vaccine rotavirus infection. Pediatr Infect Dis J 1998; 17:924-5; PMID:9802640; http://dx.doi.org/10.1097/00006454-199810000-00018
  • American Acacdemy of Pediatrics. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. American Academy of Pediatrics. Pediatrics 1998; 102:1483-91; PMID:9832589; http://dx.doi.org/10.1542/peds.102.6.1483
  • Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11-22; PMID:16394298; http://dx.doi.org/10.1056/NEJMoa052434
  • Velazquez FR, Colindres RE, Grajales C, Hernandez MT, Mercadillo MG, Torres FJ, Cervantes-Apolinar M, DeAntonio-Suarez R, Ortega-Barria E, Blum M, et al. Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico. Pediatr Infect Dis J 2012; 31:736-44; PMID:22695189; http://dx.doi.org/10.1097/INF.0b013e318253add3
  • Carlin JB, Macartney KK, Lee KJ, Quinn HE, Buttery J, Lopert R, Bines J, McIntyre PB. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program. Clinl Infect Dis 2013; 57:1427-34; PMID:23964090; http://dx.doi.org/10.1093/cid/cit520
  • Cortese MM, Parashar UD, Centers for Disease C, Prevention. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009; 58:1-25; PMID:19194371
  • Haber P, Patel M, Izurieta HS, Baggs J, Gargiullo P, Weintraub E, Cortese M, Braun MM, Belongia EA, Miller E, et al. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics 2008; 121:1206-12; PMID:18519491; http://dx.doi.org/10.1542/peds.2007-3793
  • Belongia EA, Irving SA, Shui IM, Kulldorff M, Lewis E, Yin R, Lieu TA, Weintraub E, Yih WK, Li R, et al. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J 2010; 29:1-5; PMID:19907356; http://dx.doi.org/10.1097/INF.0b013e3181af8605
  • Eng PM, Mast TC, Loughlin J, Clifford CR, Wong J, Seeger JD. Incidence of intussusception among infants in a large commercially insured population in the United States. Pediatr Infect Dis J 2012; 31:287-91; PMID:22173141; http://dx.doi.org/10.1097/INF.0b013e31824213b1
  • Loughlin J, Mast TC, Doherty MC, Wang FT, Wong J, Seeger JD. Postmarketing evaluation of the short-term safety of the pentavalent rotavirus vaccine. Pediatr Infect Dis J 2012; 31:292-6; PMID:22173146; http://dx.doi.org/10.1097/INF.0b013e3182421390
  • Patel MM, Steele D, Gentsch JR, Wecker J, Glass RI, Parashar UD. Real-world impact of rotavirus vaccination. Pediatr Infect Dis J 2011; 30:S1-5; PMID:21183833; http://dx.doi.org/10.1097/INF.0b013e3181fefa1f
  • Richardson V, Parashar U, Patel M. Childhood diarrhea deaths after rotavirus vaccination in Mexico. N Engl J Med 2011; 365:772-3; PMID:21864191; http://dx.doi.org/10.1056/NEJMc1100062
  • Ministry of Health of Brazil. National Calendar of Vaccination. 2014; [cited 1 December 2015]; available from: http://portalsaude.saude.gov.br/index.php/o-ministerio/principal/leia-mais-o-ministerio/197-secretaria-svs/13600-calendario-nacional-de-vacinacao
  • Therapeutic Goods Authority of the Australian Government Department of Health. Rotavirus vaccination and the risk of intussusception. 2013; [cited 1 December 2015]; available from: http://www.tga.ogv.au/alert/rotavirus-vaccination-and-risk-intussusception-0#.U7DWdo2Sx8M
  • Ministry of Health of Mexico. Vaccination schedule. 2015; [cited 1 December 2015]; available from: http://www.censia.salud.gob.mx/contenidos/vacunas/esquema.html
  • Strikas RA, Centers for Disease C, Prevention, Advisory Committee on Immunization P, Group ACAIW. Advisory committee on immunization practices recommended immunization schedules for persons aged 0 through 18 years–United States, 2015. MMWR Morb Mortal Wkly Rep 2015; 64:93-4; PMID:25654610
  • World Health Organization. Global advisory committee on vaccine safety, 11-12 December 2013. Wkly Epidemiol Rec 2014; 89:53-60; PMID:24707510
  • World Health Organization. Global advisory committee on vaccine safety, report of meeting held 17-18 June 2009. Wkly Epidemiol Rec 2009; 84:325-32; PMID:19860024
  • World Health Organization. Meeting of the strategic advisory group of experts on immunization, April 2012–conclusions and recommendations. Wkly Epidemiol Rec 2012; 87:201-16; PMID:24340402
  • Mpabalwani EM, Chitambala P, Chibumbya JN, Matapo B, Mutambo H, Mwenda JM, Babaniyi O, Munkonge L. Intussusception incidence rates in 9 Zambian hospitals, 2007-2011: prerotavirus vaccine introduction. Pediatr Infect Dis J 2014; 33(Suppl 1):S94-8; PMID:24343623; http://dx.doi.org/10.1097/INF.0000000000000055
  • Ngendahayo E, Bonane A, Ntakiyiruta G, Munyanshongore A, Muganga N, Bikoroti J, Mwenda JM, Tate JE, Ngabo F. Preparing for safety monitoring after rotavirus vaccine implementation: a retrospective review of intussusception cases among children at a large teaching hospital in Rwanda, 2009-2012. Pediatr Infect Dis J 2014; 33 (Suppl 1):S99-S103; PMID:24343624; http://dx.doi.org/10.1097/INF.0000000000000093
  • Omore R, Osawa F, Musia J, Rha B, Ismail A, Kiulia NM, Moke F, Vulule J, Wainaina AM, Tole J, et al. Intussusception cases among children admitted to referral hospitals in Kenya, 2002-2013: Implications for monitoring postlicensure safety of rotavirus vaccines in Africa. J Pediatr Infect Dis Soc 2015; PMID:26407281
  • Armah GE, Breiman RF, Tapia MD, Dallas MJ, Neuzil KM, Binka FN, Sow SO, Ojwando J, Ciarlet M, Steele AD. Immunogenicity of the pentavalent rotavirus vaccine in African infants. Vaccine 2012; 30(Suppl 1):A86-93; PMID:22520142; http://dx.doi.org/10.1016/j.vaccine.2011.10.006
  • Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, Podder G, Vu DT, Le TP, Luby SP, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:615-23; PMID:20692031; http://dx.doi.org/10.1016/S0140-6736(10)60755-6
  • Warfield KL, Blutt SE, Crawford SE, Kang G, Conner ME. Rotavirus infection enhances lipopolysaccharide-induced intussusception in a mouse model. J Virol 2006; 80:12377-86; PMID:17005639; http://dx.doi.org/10.1128/JVI.01185-06
  • Greenberg H. Potential for intussusception using different vaccine candidates. Rotavirus Vaccination & Intussusception Workshop. Washington, D.C., 2014
  • Williams K, Koyama T, Schulz D, Kaluza GL, Pautler RG, Weisbrodt N, Conner ME. Use of fluoroscopy to study in vivo motility in mouse pups. J Pediatr Gastroenterol Nutr 2011; 52:679-85; PMID:21593642; http://dx.doi.org/10.1097/MPG.0b013e31820a0e86
  • Killoran KE, Miller AD, Uray KS, Weisbrodt NW, Pautler RG, Goyert SM, van Rooijen N, Conner ME. Role of innate immunity and altered intestinal motility in LPS- and MnCl2-induced intestinal intussusception in mice. Am J Physiol Gastrointest Liver Physiol 2014; 306:G445-53; PMID:24407593; http://dx.doi.org/10.1152/ajpgi.00264.2013
  • Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, Goyal N, Kawade A, Kang G, Rathore SS, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet 2014; 383:2136-43; PMID:24629994; http://dx.doi.org/10.1016/S0140-6736(13)62630-6